Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy

Urology

Volumn 78, Issue 6, 2011, Pages 1235-1239

  Minamida, Satoru ^a   Satoh, Takefumi ^a   Tabata, Kenichi ^a   Kimura, Masaki ^a   Tsumura, Hideyasu ^a   Kurosaka, Shinji ^a   Matsumoto, Kazumasa ^a   Fujita, Tetsuo ^a   Iwamura, Masatsugu ^a   Baba, Shiro ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBAPENEM; LEVOFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PROSTATITIS; DIGITAL RECTAL EXAMINATION; ESCHERICHIA COLI; FECES CULTURE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATITIS; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BIOPSY, NEEDLE; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FLUOROQUINOLONES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OFLOXACIN; PREVALENCE; PROSTATE; PROSTATITIS; RECTUM;

EID: 82955227636     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.07.1392     Document Type: Article

References (27)

1. R. Tal, P.M. Livne, and D.M. Lask Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy J Urol 169 2003 1762 1765
2. H.M. Taylor, and J.B. Bingham Antibiotic prophylaxis for transrectal prostate biopsy J Antimicrob Chemother 39 1997 115 117
3. D.A. Kapoor, I.W. Klimberg, and G.H. Malek Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy Urology 52 1998 552 558
4. K.C. Shandera, G.P. Thibault, and G.E. Deshon Jr Variability in patient preparation for prostate biopsy among American urologists Urology 52 1998 644 646
5. K.G. Naber, and F. Sörgel Antibiotic therapyrationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue Andrologia 35 2003 331 335
6. D.C. Hooper, and J.S. Wolfson The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans Antimicrob Agents Chemother 28 1985 716 721
7. J.S. Wolfson, and D.C. Hooper Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis Antimicrob Agents Chemother 33 1989 1655 1661
8. G.L. Drusano, S.L. Preston, and M. Van Guilder A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin Antimicrob Agents Chemother 44 2000 2046 2051
9. K. Shigehara, T. Miyagi, and T. Nakashima Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis J Infect Chemother 14 2008 40 43
10. J. Feliciano, E. Teper, and M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsyare fluoroquinolones still effective prophylaxis? J Urol 179 2008 952 955
11. D. Lange, C. Zappavigna, and R. Hamidizadeh Bacterial sepsis after prostate biopsya new perspective Urology 74 2009 1200 1205
12. K. Matsumoto, T. Satoh, and S. Egawa Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men Int J Urol 12 2005 352 360
13. T. Horii, K. Tamai, and M. Mitsui Blood stream infections caused by Acinetobacter ursingii in an obstetrics ward Infect Genet Evol 11 2011 52 56
14. S.P. Hawser, S.K. Bouchillon, and D.J. Hoban Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring antimicrobial Resistance Trends (SMART) Antimicrob Agents Chemother 54 2010 3043 3046
15. National Committee for Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement (NCCLS Document M100-S20) 2010 National Committee for Clinical Laboratory Standards Wayne, PA
16. J.S. Wolf Jr, C.J. Bennett, and R.R. Dmochowski Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel: best practice policy statement on urologic surgery antimicrobial prophylaxis J Urol 179 2008 1379 1390
17. A. Heidenreich, M. Bolla, and S. Joniau Guidelines on prostate cancer: European Association of Urology2010 updatefrom http://www.uroweb.org/gls/pdf/ Prostate%20Cancer%202010%20June%2017th.pdf Accessed March 31, 2011
18. R. Colodner, Y. Keness, and B. Chazan Antimicrobial susceptibility of community-acquired uropathogens in northern Israel Int J Antimicrob Agents 18 2001 189 192
19. G. Kahlmeter ECO.SENS Project An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project J Antimicrob Chemother 51 2003 69 76
20. D.M. Livermore, D. James, and M. Reacher Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999 Emerging Infect Dis 8 2002 473 478
21. W. Goettsch, W. van Pelt, and N. Nagelkerke Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands J Antimicrob Chemother 46 2000 223 228
22. K. Ishikawa, T. Matsumoto, and M. Yasuda The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy J Infect Chemother 17 2011 126 138
23. M.A. Liss, A. Chang, and R. Santos Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy J Urol 185 2011 1283 1288
24. B.C. Griffith, A.F. Morey, and M.M. Ali-Khan Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk J Urol 168 2002 1021 1023
25. R.R. Muder, C. Brennen, and A.M. Goetz Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs Medical Center Antimicrob Agents Chemother 35 1991 256 258
26. E. Ozden, Y. Bostanci, and K.Y. Yakupoglu Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy Urology 74 2009 119 123
27. K.E. Aldridge, D. Ashcraft, and K. Cambre Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species Antimicrob Agents Chemother 45 2001 1238 1243